Prasol Chemicals Limited was originally incorporated as "Prachi Poly Products Private Limited" in January 1992, subsequently converted into a public company in 1995, and renamed "Prasol Chemicals Limited" in 2007. The company is a leading, forward-integrated manufacturer of specialty chemicals in India, focusing on acetone-based and phosphorus-based chemical derivatives utilizing complex, differentiated, and automated chemistries. Its underlying business model is centered on importing raw materials at a high scale, adding value through automated synthesis, and manufacturing custom specialty molecules to achieve product and process customization for a wide variety of downstream industries. The company is certified as a "Three-Star Export House" by the Government of India, reflecting its global standards and operational scale.
The company categorizes its extensive product portfolio into three main chemical domains: acetone-based specialty chemicals, phosphorus-based specialty chemicals, and other specialty chemicals (including customized non-acetone and non-phosphorus surfactants, performance additives, ethers, esters, polymers, and acids). Its core value proposition lies in serving as an essential chemical input partner for key application industries, including performance chemicals (lubricant additives and mining flotation reagents), PICA (paints, inks, construction, and adhesives), pharmaceuticals, agrochemicals, and home and personal care. During the calendar years 2022 to 2025, Prasol established itself as the largest importer of acetone in India to produce a highly diversified range of acetone-based derivatives like diacetone alcohol and hexylene glycol, while maintaining its position as the sole manufacturer of isophorone in India. Similarly, the company ranks among the top five importers and users of yellow phosphorus in India to synthesize high-value phosphorus derivatives like phosphorus pentasulphide and polyphosphoric acid.
As of July 15, 2026, Prasol served a highly diversified B2B customer base consisting of over 1,600 clients globally, including marquee entities such as Alembic Pharmaceuticals Limited, Auchtel Products Limited, Bharat Rasayan Limited, Carl Bechem Lubricants (India) Private Limited, Clean Science and Technology Limited, Croda India Company Private Limited, and Coromandel International Limited. Sourcing and supply relationships with top clients range from eight to over fifteen years, ensuring strong customer stickiness and revenue visibility. Geographically, while the domestic Indian market represents its largest consumption base, the company has successfully expanded its global footprint, exporting its specialty chemical formulations to 69 countries across the Asia-Pacific (APAC) region, Europe, North America, and South America, with export revenues accounting for 27.29% of total operations in Fiscal 2026.
Prasol's primary manufacturing operations are centralized across two state-of-the-art facilities in Maharashtra: the Khopoli Manufacturing Facility (established in 1995, spanning 120,604.00 square meters) and the greenfield Mahad Manufacturing Facility (established in 2020, spanning 119,423.00 square meters), with a combined annual installed capacity of 98,644 metric tons (MT). At the Khopoli plant, installed capacity grew from 61,214 MT in FY24 to 78,784 MT in FY26, with actual production volumes of 43,907 MT, 48,650 MT, and 63,256 MT, representing capacity utilization levels of 71.73% (FY24), 68.60% (FY25), and 80.29% (FY26). Conversely, the Mahad facility, which was set up in 2020, experienced lower capacity utilization of 12.72% (FY24) and 25.18% (FY25) due to global agrochemical de-stocking and a major H2S gas leak shutdown from October 27, 2023, to May 3, 2024, before recovering to 44.09% utilization in FY26 with an annual production of 8,756 MT (out of 19,860 MT capacity).
The company's strong technological edge is supported by its dedicated, in-house Research and Development (R&D) center located at the Khopoli facility. The R&D laboratory houses advanced process development equipment, including fluidized bed reactors, distillation columns, and pilot-scale batch synthesis setups, operated by a specialized team of 37 professionals, including 4 PhD holders and 25 chemists. R&D expenditure stood at Rs 33.39 million (0.27% of total income) in Fiscal 2026, compared to Rs 19.81 million (0.20%) in Fiscal 2025 and Rs 21.58 million (0.24%) in Fiscal 2024. This active R&D focus drives a robust pipeline of 40 products at various stages of development, with 9 having successfully cleared pilot-scale testing, positioned to drive future forward and backward integration.
As per financial performance, Prasol Chemicals Limited has posted total income / net profits of Rs 887.56 Cr / Rs 18.13 Cr (FY24), Rs 1,015.54 Cr / Rs 43.57 Cr (FY25) and Rs 1,237.85 Cr / Rs 83.12 Cr (FY26). So as per previous financials data, the company has shown robust top-line and net profit expansion over the last three financial periods, accompanied by consistent balance sheet deleveraging as its net debt-to-equity ratio improved from 0.22x in Fiscal 2024 to 0.19x in Fiscal 2026. Company has an average EPS of Rs 10.19 and average RoNW of 14.15% for the last three fiscals. Based on the pre-issue book value, the issue is priced at a Pre-Issue P/BV of 8.74 as per NAV of Rs 77.33 as on 31.03.26. Factoring in the fresh issue proceeds, the Post-Issue P/BV stands at 7.57. If we attribute the latest earnings of FY24, FY25, and FY26 to the expanded equity base post-issue, then the asking price is at a Post-Issue P/E of around 220.66, 91.83, and 48.13 respectively. As per RHP, a comparison between listed peers shows that the average peer P/E is 61.74x (ranging from 17.12x for Excel Industries to 206.68x for Yasho Industries), indicating that Prasol's valuation represents a reasonable discount to peer averages, although it trades at a premium to legacy commodity peers.
On BRLM's front, DAM Capital Advisors Limited (acting as the sole Book Running Lead Manager) is associated with this IPO, and DAM Capital Advisors Limited has handled 17 IPOs in the last three fiscal years. (as on 03.09.26)
✍️ Post a Comment